Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Oncolytics Biotech Inc. (ONCY) Debt to Capital Ratio data is not available for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-9.44M |
|
-- |
|
-- |
|
$9.38M |
|
$-9.38M |
|
$0.04M |
|
$-9.34M |
|
$-9.34M |
|
$-9.44M |
|
$-9.44M |
|
$-9.44M |
|
$-9.44M |
|
$-9.38M |
|
$-9.36M |
|
119.74M |
|
119.74M |
|
$-0.08 |
|
$-0.08 |
|
| Balance Sheet Financials | |
$7.07M |
|
$0.20M |
|
$0.60M |
|
$7.67M |
|
$5.22M |
|
-- |
|
$8.61M |
|
$13.84M |
|
$-6.17M |
|
$-6.17M |
|
$-6.17M |
|
124.64M |
|
| Cash Flow Statement Financials | |
$-15.43M |
|
$-0.01M |
|
$14.38M |
|
$5.20M |
|
$4.12M |
|
$-1.09M |
|
$4.09M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.35 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
-- |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-15.44M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
153.11% |
|
153.11% |
|
-123.09% |
|
153.11% |
|
$-0.05 |
|
$-0.13 |
|
$-0.13 |
|